Al-Mamgani A, et al. - The specialists explored the compliance and the impact of the cumulative dose of cisplatin on overall survival (OS), disease-free survival (DFS), loco-regional control (LRC), and distant-metastasis-free survival (DMFS). Their findings increased the bulk of slowly growing evidence on the optimal cumulative dose of cisplatin. In addition, baseline GFR might predict compliance.